This study shows that remdesivir and dexamethasone combination therapy can be considered as a suitable treatment choice for pregnant women infected with COVID‐19. It is worth mentioning that more studies are required to evaluate the efficacy and side effects of remdesivir monotherapy and its combination with dexamethasone during pregnancy.

Objective: The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus (SARS-CoV 2), has expanded rapidly all over the world and is a pandemic now. Pregnant women experience immunological and physiologic changes that make them more susceptible to viral infections. Case Report: We described a case report of a term singleton pregnant woman with the manifestation of acute myocardial injury. In echocardiography, reduced left and right ventricular ejection fraction was seen in the absence of obstructive coronary artery disease. This phenomenon was highly suggestive of cardiomyopathy. Conclusion: Due to the fact of the immunological and physiological changes during pregnancy, women should be aware of viral infections, especially COVID-19, which is prevalent all over the world. Cardiomyopathy might be classified as one of the manifestations of COVID-19 in pregnant women. Further investigations should be considered for the absolute relationship between COVID-19 and cardiomyopathy to improve pregnant women’s health.